logo

For the Inventor, By the Inventor

Saffron Walden, United Kingdom

Grant Wishart

This inventor holds 19 USPTO granted patents and 5 published patent applications and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Nimbus Saturn, Inc., Chdi Foundation, Inc., Calliditas Therapeutics Suisse Sa. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Grant Wishart. Retrieved from https://idiyas.com/inventor/grant-wishart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.5

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Airdrie, GB (2023)
  • Saffron Walden, GB (2017 - 2024)

Company Filing History:

goldMedal10 out of 10 
 
Nimbus Saturn, Inc.
 patents
silverMedal8 out of 56 
 
Chdi Foundation, Inc.
 patents
bronzeMedal1 out of 3 
 
Calliditas Therapeutics Suisse Sa
 patents

Years Active: 2017-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
HPK1 Antagonists
NADPH Oxidase Inhibitors
Histone Deacetylase Inhibitors
Substituted Pyrrolo Compounds
Isoindolin-1-ones
ATM Kinase Inhibitors
Compositions
Methods of Use
19 patents (USPTO):Explore Patents
1. 12466841 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists (2025-11-11),
2. 12252488 - HPK1 antagonists and uses thereof (2025-03-18),
3. 12215105 - HPK1 antagonists and uses thereof (2025-02-04),
4. 12202816 - Compounds as NADPH oxidase inhibitors (2025-01-21),
5. 12071442 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists (2024-08-27),
6. 11926625 - HPK1 antagonists and uses thereof (2024-03-12),
7. 11685734 - ATM kinase inhibitors and compositions and methods of use thereof (2023-06-27),
8. 11548890 - HPK1 antagonists and uses thereof (2023-01-10),
9. 11078201 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists (2021-08-03),
10. 11034694 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists (2021-06-15),
11. 11028085 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists (2021-06-08),
12. 11021481 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists (2021-06-01),
13. 10457675 - Histone deacetylase inhibitors and compositions and methods of use thereof (2019-10-29),
14. 10106535 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-10-23),
15. 10065948 - Histone deacetylase inhibitors and compositions and methods of use thereof (2018-09-04),

Title: Grant Wishart - Innovator from Saffron Walden

Introduction: Grant Wishart is a renowned inventor hailing from Saffron Walden, Great Britain. His innovative spirit and dedication to creating groundbreaking solutions have earned him recognition in the field of technology and beyond.

Latest Patents: Grant Wishart holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and healthcare technologies.

Career Highlights: Throughout his career, Grant Wishart has demonstrated a keen ability to transform ideas into tangible inventions that have the potential to improve lives and industries. His contributions to the field of innovation have been widely celebrated.

Collaborations: Grant Wishart has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market. His collaborative efforts have resulted in successful products that have made a significant impact.

Conclusion: Grant Wishart's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His work serves as a testament to the power of creativity and ingenuity in driving positive change in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…